Centene posts $3.3B profit for 2024, boosted by Medicare drug plan and Obamacare

St. Louis Business Journal

Feb 4, 2025

Centene Corp. (NYSE: CNC) on Tuesday reported a $3.3 billion profit for last year, a 22% increase over 2023 as a sharp increase in its Medicare prescription drug plan membership he…